Pacific Biosciences (NASDAQ:PACB) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Pacific Biosciences missed estimated earnings by 6.25%, reporting an EPS of $-0.34 versus an estimate of $-0.32.
Revenue was up $4.86 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.06 which was followed by a 11.93% drop in the share price the next day.
Here’s a look at Pacific Biosciences’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.31 | -0.28 | -0.22 | -0.20 |
| EPS Actual | -0.37 | -0.30 | -0.23 | -0.21 |
| Revenue Estimate | 32.82M | 36.12M | 33.23M | 29.89M |
| Revenue Actual | 33.17M | 36.02M | 34.89M | 30.61M |
To track all earnings releases for Pacific Biosciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
